Co-Diagnostics Q1 2024 GAAP EPS $(0.31) Misses $(0.21) Estimate, Sales $467.854K Miss $3.050M Estimate
Co-Diagnostics Q1 2024 GAAP EPS $(0.31) Misses $(0.21) Estimate, Sales $467.854K Miss $3.050M Estimate
联合诊断2024年第一季度GAAP每股收益（0.31）未达到预期（0.21），销售额为46.7854万美元，未达到30.5亿美元的预期
Co-Diagnostics (NASDAQ:CODX) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.21) by 47.62 percent. This is a 55 percent decrease over losses of $(0.20) per share from the same period last year. The company reported quarterly sales of $467.854 thousand which missed the analyst consensus estimate of $3.050 million by 84.66 percent. This is a 22.28 percent decrease over sales of $601.957 thousand the same period last year.
联合诊断（纳斯达克股票代码：CODX）公布的季度亏损为每股0.31美元，比分析师普遍预期的0.21美元（0.21美元）低47.62个百分点。这比去年同期每股亏损0.20美元（0.20）下降了55％。该公司公布的季度销售额为467,854美元，比分析师普遍预期的30.5亿美元低84.66％。这比去年同期的601,957美元的销售额下降了22.28％。